The market for RNA Polymerase I (Pol I) inhibitors is a nascent, highly specialized area of oncology drug discovery with strong biological rationale. Polymerase I is the enzyme that transcribes ...
Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): a phase II trial in men with castration resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2016 ...
Response to radiation therapy in solitary fibrous tumor/hemangiopericytoma. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text component.
Shenzhen Yangli Pharmaceutical Technology Co. Ltd. has patented poly (ADP-ribose) polymerase 1 (PARP-1; ARTD1) inhibitors reported to be useful for the treatment of cancer, ischemia and ...
Slap Pharmaceuticals LLC have identified new poly (ADP-ribose) polymerase 1 (PARP-1; ARTD1) inhibitors reported to be useful for the treatment of cancer.
The ribosome is one of the most iconic machines in molecular biology—a complex structure that reads a recipe written in RNA to assemble amino acid building blocks into new proteins. Ting Zhu of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback